Conviction over time

Sentiment weighted by conviction, oldest to newest — above the line is bullish

Trades

What he actually did, newest first

• 31 May 26

  Bought some Wolfspeed in the beginning of the month.

  buy post →
• 31 May 26

  Bought some Fluence in the beginning of the month.

  buy post →
• 31 May 26

  Sold his TMDX shares.

  sell post →
• 31 May 26

  Sold ASML shares (+13% in 3 months) to fund a SK Hynix purchase.

  sell post →
• 31 May 26

  Bought SK Hynix using proceeds from selling ASML; wishes he had bought more three months ago (+114% since).

  buy post →
• 07 May 26

  Sold TMDX shares today

  sell post →
• 07 May 26

  Used TMDX sale proceeds to add to FLNC position

  add post →
• 06 May 26

  Down 20% premarket and now only 1.7% of portfolio, so probably going to sell and move on.

  sell post →
• 01 May 26

  sold this month to raise cash

  sell post →
• 01 May 26

  sold this month to raise cash

  sell post →

Reasoning trail

Every post mentioning TMDX, newest first — the thesis as it was built and revised

• 31 May 26

  Monthly portfolio update: MTD +40.4%, YTD +97.8%. Bought WOLF and FLNC early in the month, sold TMDX, and sold ASML to fund a SK Hynix purchase (wishes he'd bought more three months ago). Cash allocation ~11.6% and building slightly via savings, not sales. Reviews all 14 core holdings with performance, allocation and outlook: PL (target $60 by year end, earnings 4/6), RKLB (surged on strong earnings), OUST (long-term hold, no longer buy territory), PLTR (favorite AI software play, #1 holding), SK Hynix (regrets not buying more), AMPX (bullish long-term on batteries/drones), IREN (highest-cost holding, datacenter thesis), MRVL (photonics center, healthy balance sheet), ASM.AS (longest-held, safe-haven, €1,000 target where he may trim), Filtronic (SpaceX GaN amp supplier), WOLF (bullish long-term, BoA target >$80), FLNC (Hyperscaler contracts, next quarters crucial), GOOGL (could become most valuable company), HIMS (small 3.7% allocation, may add).

  bullish high post →
• 08 May 26

  Clarifies he sold TMDX shares, not AMPX, using an attached screenshot of his own earlier post as proof; he still holds AMPX and used the TMDX proceeds to add to FLNC.

  neutral medium post →
• 08 May 26

  Explains he sold TMDX to concentrate his portfolio further since he lacks time to monitor many stocks; TMDX had shrunk to 1% of his portfolio after results, so he moved the money into Fluence.

  neutral medium post →
• 08 May 26

  Explains selling TMDX: after results it was only 1% of his portfolio, and he wanted to trim his 17 holdings down to 12.

  neutral medium post →
• 07 May 26

  Announces he sold TMDX and used the proceeds to add to FLNC, keeping cash allocation at ~15%. Also flags he'll review AMPX earnings (already listened) and plans to listen to IREN and RKLB earnings calls, both of which he holds, noting aftermarket looks great for the latter two.

  bullish medium post →
• 06 May 26

  Author reports a rough premarket earnings day across his portfolio: TMDX -20%, WOLF -12%, OUST -6%. Not worried about WOLF/OUST but plans to sell TMDX since it's now a tiny 1.7% position.

  mixed medium post →
• 01 May 26

  Publishes management-quality scores for his full current holding list under his rating framework: GOOGL 97, FTC 96, SK Hynix 93, ASM.AS 92, OUST 90, PL 89, MRVL 88, PLTR 87, TMDX 87, HIMS 85, RKLB 79, AMPX 75, FLNC 73, IREN 35 — generally praising execution and capital discipline, with dilution and guidance misses as the main detractors, and IREN scored lowest for promotional narrative pivots and heavy dilution.

  mixed medium post →
• 01 May 26

  Monthly portfolio update: best month ever at +48.49% return. Raised cash by selling POET, HOOD and CROWD; only buy was FTC (Filtronic). Wants to add to FTC (currently 4.5% allocation) but is waiting for a better entry. 45% of holdings report earnings next week, especially TMDX and FLNC, his worst performers now under 3% allocation each — earnings will decide whether he trims or adds. Plans to move toward a more concentrated ~12-stock portfolio and expects more trading this month.

  bullish high post →
• 11 Apr 26

  Announces he's first place in a stock-picking fantasy league (Fantasy Stock League by @ThetaForgeX and @muted_money), and shares his virtual portfolio including $PL, $AMPX, $PLTR, and $RKLB as favourite real-life picks. Screenshot confirms a portfolio allocation chart topped by PL, AMPX, PLTR, FLNC, RKLB, TMDX, ASML, LOW, LMT, C.

  bullish medium post →
• 05 Apr 26

  Monthly portfolio update: up 6.9% in March, led by PL, PLTR, RKLB and AMPX; initiated four new positions (OUST, POET, MRVL, SK Hynix), added to HIMS; TMDX, HOOD, FLNC and IREN declined; plans to cut cash from 20% to 10% and consolidate from 16 to 11 holdings.

  bullish high post →
• 27 Feb 26

  February portfolio recap: -15.6% for the month but only -0.9% YTD after January's run-up. Attributes the drawdown to a valuation reset in high-conviction AI/software names, volatility in high-beta growth holdings, and resilience from semiconductor/foundational holdings. Made zero trades in February, reaffirms conviction in his 16-company portfolio, framing inactivity as a deliberate choice not to interrupt long-term compounding.

  bullish high post →
• 25 Feb 26

  Defends TMDX after a 4% post-earnings drop, saying there's nothing to dislike about the quarter and the market is misreading it.

  bullish medium post →
• 25 Feb 26

  Praises TMDX's results as a big fan of the company, discloses he added shares in September 2025, and expects a new all-time high in 2026.

  bullish high post →
• 25 Feb 26

  Agrees TMDX delivered great earnings and a conclusive call, thanking the parent poster for the summary.

  bullish low post →
• 24 Feb 26

  Explains the market drop was tied to the TransMedics earnings call, on a day with heavy earnings volume.

  neutral low post →
• 24 Feb 26

  As a TMDX shareholder, lays out a bullish Q4/2025 thesis: sticky NOP program growth, expanding in-house aviation/logistics moat, kidney program TAM expansion coming in 2026, and aggressive European restructuring.

  bullish high post →
• 24 Feb 26

  Calls TMDX's report stellar (stock +9%), citing 32% revenue growth from its organ transport/aviation network and a 25% 2026 growth outlook, with upcoming European expansion, a kidney program, and new heart/lung trials as next growth phases.

  bullish high post →
• 02 Feb 26

  January portfolio update: up 11.56% for the month with no trades made. For the first time in two years PLTR is not his largest holding; PL is now the top position. Full 16-name portfolio with allocation weights disclosed.

  bullish high post →